Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Audax Group is a leading alternative investment manager focused on building value in middle market companies across North America. Through its private equity and private debt businesses, it has invested over $7 billion in more than 140 platform companies and over 1,000 add-on acquisitions since its founding in 1999. The group has significant experience investing in healthcare and life sciences through portfolio companies but does not develop drugs or therapies itself.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Audax Group.